We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Information on EC 1.1.1.30 - 3-hydroxybutyrate dehydrogenase for references in articles please use BRENDA:EC1.1.1.30Word Map on EC 1.1.1.30
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3-hydroxybutyrate dehydrogenase
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH + H+
(R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH + H+
enzyme is completely dependent on the presence of phospholipid for activity
-
(R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH + H+
; ordered Bi Bi mechanism, NAD+ first substrate, NADH last product to leave
-
-
-
(R)-3-hydroxybutanoate + NAD+ = acetoacetate + NADH + H+
the enzyme shows a dynamical reaction mechanism. In the catalytic site, a water molecule is trapped by the catalytic Tyr155 and Ser142 residues in the vicinity of the bound NAD+ and acetate, substrate binding structure, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Synthesis and degradation of ketone bodies
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-3-hydroxybutanoate:NAD+ oxidoreductase
Also oxidizes other 3-hydroxymonocarboxylic acids.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3-D-hydroxybutyrate dehydrogenase
-
-
-
-
3-hydroxybutyrate dehydrogenase
-
-
-
-
3-hydroxybutyrate dehydrogenase 2
-
3-hydroxybutyrate dehydrogenase-2
-
acetoacetyl-CoA reductase
-
-
beta-hydroxybutyrate dehydrogenase
beta-hydroxybutyric acid dehydrogenase
-
-
-
-
beta-hydroxybutyric dehydrogenase
-
-
-
-
D(-)-3-hydroxybutyrate dehydrogenase
-
D-(-)-3-hydroxybutyrate dehydrogenase
D-3-hydroxybutyrate dehydrogenase
D-beta-hydroxybutyrate dehydrogenase
hydroxybutyrate oxidoreductase
-
-
-
-
NAD-beta-hydroxybutyrate dehydrogenase
-
-
-
-
3HBDH
-
-
BDH
-
-
-
-
BDH1
-
BDH2
-
BDH3
-
BdhA
-
beta-hydroxybutyrate dehydrogenase
-
-
-
-
beta-hydroxybutyrate dehydrogenase
-
-
D-(-)-3-hydroxybutyrate dehydrogenase
-
-
-
-
D-(-)-3-hydroxybutyrate dehydrogenase
-
D-(-)-3-hydroxybutyrate dehydrogenase
-
-
D-3-hydroxybutyrate dehydrogenase
-
-
-
-
D-3-hydroxybutyrate dehydrogenase
-
-
D-3-hydroxybutyrate dehydrogenase
-
D-3-hydroxybutyrate dehydrogenase
-
-
D-3-hydroxybutyrate dehydrogenase
-
-
D-3-hydroxybutyrate dehydrogenase
-
-
D-3-hydroxybutyrate dehydrogenase
Q9AE70
-
D-beta-hydroxybutyrate dehydrogenase
-
-
-
-
D-beta-hydroxybutyrate dehydrogenase
-
-
D-beta-hydroxybutyrate dehydrogenase
-
-
HBD
-
-
HBDH
-
-
additional information
-
the enzyme belongs to the SDR family
additional information
-
the enzyme belongs to the family of short-chain dehydrogenases/reductases
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
SwissProt
brenda
-
-
-
brenda
-
-
-
brenda
-
286513 , 286514 , 286516 , 286517 , 286521 , 286522 , 286525 , 286527 , 286528 , 286530 , 286535 , 286538 , 286540 , 286542 , 286543
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
UniProt
brenda
-
-
-
brenda
-
-
-
brenda
serogroup 6
UniProt
brenda
serogroup 6
UniProt
brenda
-
UniProt
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
-
-
brenda
-
Uniprot
brenda
-
-
-
brenda
-
-
-
brenda
enzyme shows hysteresis, lag phase in progress curve
-
-
brenda
-
Q5KST5
SwissProt
brenda
recombinant enzyme
Q5KST5
SwissProt
brenda
-
Q9AE70
SwissProt
brenda
-
-
-
brenda
-
SwissProt
brenda
T1
UniProt
brenda
T1
SwissProt
brenda
-
SwissProt
brenda
T1
UniProt
brenda
T1
SwissProt
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
-
Gln94, His144, Lys152, and Gln196 form hydrogen bonds with carboxyl and/or ketone group of acetoacetate, Trp187, Trp257 form hydrophobic interactions with the carbon atoms of acetoacetate, and Ser142 and Tyr155 are directly related to the catalytic mechanism
malfunction
inhibiting expression of the 3-hydroxybutyrate dehydrogenase-2 gene results in abnormal accumulation of intracellular iron, increased oxidative stress, and mitochondrial iron deficiency
malfunction
enzyme inactivation in developing zebrafish embryo results in heme deficiency and delays erythrocyte maturation
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-2-hydroxybutanoate + NAD+
acetoacetate + NADH
-
isoenzyme from heavy mitochondria and isoenzyme from light mitochondria show no significant difference in activity
-
-
?
(R)-3-hydroxybutanoate + 3-acetylpyridine adenine dinucleotide
acetoacetate + 3-acetylpyridine adenine dinucleotideH2
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
(R)-3-hydroxybutanoate + NADH + H+
acetoacetate + NAD+
(R)-3-hydroxybutanoate + NADP+
acetoacetate + NADPH
Q5KST5
activity with NADP+ is 2% of the activity with NAD+
-
-
?
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
2-hydroxypropansulfonate + NAD+
acetonylsulfonate + NADH
-
-
-
r
2-methyl-3-hydroxybutyrate + NAD+
2-methylacetoacetate + NADH
-
-
-
r
3-hydroxyvalerate + NAD+
3-oxovalerate + NADH + H+
4-hydroxybutanoate + NAD+
acetoacetate + NADH
-
isoenzyme from heavy mitochondria shows 40% lower activity than enzyme fromlight mitochondria
-
-
?
acetoacetate + NADH + H+
(R)-3-hydroxybutanoate + NAD+
-
-
-
-
?
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
L-threonine + NAD+
?
Q5KST5
-
-
-
?
levulinic acid + NADH + H+
4-hydroxyvaleric acid + NAD+
poly-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
additional information
?
-
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
Q5KST5
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
model of the binding mode of the substrate D-3-hydroxybutyrate, Gln193 is the only residue of the substrate-binding loop that interacts directly with the substrate, NAD+ binding increases the flexibility of the substrate-binding loop and shifts the equilibrium between the open and closed forms towards the closed form, overview
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
Q9AE70
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
r
(R)-3-hydroxybutanoate + NADH + H+
acetoacetate + NAD+
-
-
-
-
r
(R)-3-hydroxybutanoate + NADH + H+
acetoacetate + NAD+
-
the enzyme is involved in poly(3-hydroxybutyrate) biosynthesis together with acetoacetyl-CoA thiolase and PHB synthase, pathway overview, intracellular concentrations of key metabolites, i.e. CoA, acetyl-CoA, 3HB-CoA, NAD+/NADH, determine whether a cell accumulates or degrades PHB
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
strain SA1 can degrade poly((R)-3-hydroxybutyrate), i.e. PHB
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
during hibernation, the enzyme is responsible for bioconvertion of high amounts of ketone bodies, i.e. acetoacetate and (R)-3-hydroxybutyrate, in the liver for usage as energetic fuel
-
-
r
3-hydroxyvalerate + NAD+
3-oxovalerate + NADH + H+
-
-
-
-
?
3-hydroxyvalerate + NAD+
3-oxovalerate + NADH + H+
-
-
-
-
?
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
the reversible reactions occur by shuttle movements of a hydrogen negative ion from the C3 atom of the substrate to the C4 atom of NAD+ and from the C4 atom of NADH to the C3 atom of the product. The reaction may be further coupled to the withdrawal of a proton from the hydroxyl group of the substrate by the ionized Tyr155 residue
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH1 is needed to regulate the cytoplasmic redox state as well as to utilize 3-hydroxybutyrate
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH2 is needed to regulate the cytoplasmic redox state as well as to utilize 3-hydroxybutyrate
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH3 is specialized to utilize 3-hydroxybutyrate
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH3 is specialized to utilize 3-hydroxybutyrate
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH2 is needed to regulate the cytoplasmic redox state as well as to utilize 3-hydroxybutyrate
-
-
r
D-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
BDH1 is needed to regulate the cytoplasmic redox state as well as to utilize 3-hydroxybutyrate
-
-
r
levulinic acid + NADH + H+
4-hydroxyvaleric acid + NAD+
-
only the recombinant wild type enzyme with N-terminal His-tag shows activity with levulinic acid
-
-
?
levulinic acid + NADH + H+
4-hydroxyvaleric acid + NAD+
-
the wild type enzyme shows low activity with levulinic acid, while it's a good substrate for mutant enzyme H144L/W187F
-
-
?
poly-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
r
poly-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
-
-
r
additional information
?
-
-
no activity of the wild-type enzyme with levulinic acid, enzyme mutant H144L/W187F is active with levulinic acid producing 4-hydroxyvaleric acid
-
-
-
additional information
?
-
-
enzyme activity is differently regulated in liver and brain at euthermic, prehibernating,and hibernating state
-
-
-
additional information
?
-
-
a ketone body converting enzyme in mitochondria in liver jerboa, enzyme expression, activity and metabolism at different physiological states, overview
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
(R)-3-hydroxybutanoate + NADH + H+
acetoacetate + NAD+
-
the enzyme is involved in poly(3-hydroxybutyrate) biosynthesis together with acetoacetyl-CoA thiolase and PHB synthase, pathway overview, intracellular concentrations of key metabolites, i.e. CoA, acetyl-CoA, 3HB-CoA, NAD+/NADH, determine whether a cell accumulates or degrades PHB
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
acetoacetate + NADH + H+
(R)-3-hydroxybutanoate + NAD+
-
-
-
-
?
additional information
?
-
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
D0VWQ0
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
r
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
Q561X9
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
Q5ZT49
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
Q5ZT49
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
?
(R)-3-hydroxybutanoate + NAD+
acetoacetate + NADH + H+
-
-
-
-
?
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
Q767A0
strain SA1 can degrade poly((R)-3-hydroxybutyrate), i.e. PHB
-
-
r
(R)-3-hydroxybutyrate + NAD+
acetoacetate + NADH + H+
-
during hibernation, the enzyme is responsible for bioconvertion of high amounts of ketone bodies, i.e. acetoacetate and (R)-3-hydroxybutyrate, in the liver for usage as energetic fuel
-
-
r
additional information
?
-
-
enzyme activity is differently regulated in liver and brain at euthermic, prehibernating,and hibernating state
-
-
-
additional information
?
-
-
a ketone body converting enzyme in mitochondria in liver jerboa, enzyme expression, activity and metabolism at different physiological states, overview
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NADP+
-
2% of the activity with NAD+
additional information
-
no activity with NADP+/NADPH
-
NAD+
-
-
NAD+
-
-
286513 , 286514 , 286516 , 286517 , 286521 , 286522 , 286525 , 286527 , 286528 , 286530 , 286535 , 286538 , 286540 , 286542 , 286543
NAD+
-
; the substrate-binding loop, residues 187-210, is partially disordered in several subunits, in both the presence and absence of NAD+, closed conformation in the complex structure with NAD+, interactions of Val185, Thr187 and Leu189 with the cosubstrate induced the conformational change from open to closed, NAD+ binding increases the flexibility of the substrate-binding loop and shifts the equilibrium between the open and closed forms towards the closed form
NAD+
-
NAD+ is bound in a large cleft in the domain. The diphosphate group of NAD+ is covered by the small additional domain, which is supported by two extended arms allowing domain movement
NADH
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Cd2+
-
10 mM, 2fold increase in activity
Cu2+
-
10 mM, 2fold increase in activity
Zn2+
-
10 mM, 2fold increase in activity
Ca2+
stabilizes the enzyme at 10 mM
Ca2+
-
10 mM, more than 10fold increase in activity
Ca2+
-
10 mM 20% increase in activity
Mg2+
stabilizes the enzyme at 10 mM
Mg2+
-
0.1 mM, 2fold increase in activity, crude extracts
Mg2+
-
10 mM, more than 10fold increase
Mg2+
-
10 mM 41% increase in activity
Mn2+
stabilizes the enzyme at 10 mM
Mn2+
-
10 mM, more than 10fold increase in activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(DL)-2-hydroxybutyrate
-
5 mM, pH 8.5, 25°, 69% inhibition
(DL)-lactate
-
5 mM, pH 8.5, 25°C, 65% inhibition
2,4-Dichlorophenoxyacetic acid
-
inhibits the enzyme, in vivo treatment of the animals with 2,4-dichlorophenoxyacetic acid leads to strong decrease of triglycerides level and HDL cholesterol and an increase in GOT level and LDL cholesterol, and necrosis of seminiferous tubules cells in testis, hyperplasia of hepatocytes in liver and presence of multinucleated giant cells in brain, overview
2-Hydroxybutyrate
-
10 mM, 57% inhibition
2-oxobutyrate
-
10 mM, 29% inhibition
3-hydroxybutyrate
-
substrate inhibition at concentrations above 20 mM, 50% inhibition at 200 mM, cyanylated enzyme is 3fold more active at high substrate concentration
4-mercapto-3-nitrobenzoate
-
derivatization of enzyme sulfhydryl groups, less than 1% residual activity
5,5'-dithiobis(2-nitrobenzoic acid)
-
0.15 mM, 63% inhibition
acetoacetyl-CoA
-
1 mM, 29% inhibition
acetyl-CoA
-
1 mM, 82% inhibition
acetylphosphonate
-
16.7 mM, pH 7, 28% inhibition
ADP
-
2.85 mM, 0.025 mM NADH, 63% inhibition, competitive inhibitor vs. NADH and NAD+, pH 7-7.5, noncompetitive vs. acetoacetate
ADP-ribose
-
competitive inhibition vs. coenzyme, noncompetitive vs. substrate
AMP
-
2.85 mM, 0.025 mM NADH, 55% inhibition, competitive inhibitor vs. NADH and NAD+, pH 7-7.5
ATP
-
2.85 mM, 0.025 mM NADH, 79% inhibition, competitive inhibitor vs. NADH and NAD+, pH 7-7.5, noncompetitive vs. acetoacetate
crotonate
-
10 mM, 20% inhibition
CuSO4
-
1 mM, 81% inhibition
D-lactate
-
5 mM, pH 8.5, 25°, 85% inhibition, uncompetitive vs. coenzyme, competitive vs. substrate
diazenedicarboxylic acid bis(dimethylamide)
dimethyl phosphate
-
16.7 mM, pH 7, 12% inhibition
dimethyloxyphosphinylacetate
-
competitive inhibitor vs. acetoacetate
EDTA
inhibition and destabilization of the enzyme at 10 mM
glucose
inhibits the enzyme when contained in the growth medium
Hg2+
inhibition at 1 mM, and destabilization at 10 mM
KCl
-
80-100 mM, 50% inhibition
LiCl
-
80-100 mM, 50% inhibition
methanephosphonic acid
-
3.3 mM, pH 7, 11% inhibition
methyl methylphosphonate
-
3.3 mM, pH 7, 13% inhibition
methyl phosphate
-
16.7 mM, pH 7, 21% inhibition
Methyl-2-methoxyphosphinylacetate
-
competitive inhibitor vs. acetoacetate
-
MnCl2
-
1 mM, 50% inhibition
NaCl
-
80-100 mM, 50% inhibition
NAD+
-
substrate inhibition, high concentrations, noncompetitive vs. beta-hydroxybutyrate
NH4Cl
-
80-100 mM, 50% inhibition
oxalate
-
16.7 mM, pH 7, 9% inhibition
Phenylarsine oxide
-
NAD+ and NADH protect against inhibition
propionate
-
5 mM, pH 8.5, 25°C, 9% inhibition
sodium acetonylphosphonate
-
3.3 mM, pH 7, 21% inhibition
sodium monomethyl acetylphosphonate
-
16.7 mM, pH 7, 60% inhibition
sodium monomethylacetonylphosphate
-
16.7 mM, pH 7, 30% inhibition
Sodium sulfide
-
competitive vs. beta-hydroxybutyrate
sodium sulfite
-
uncompetitive vs. NAD+ and acetoacetate, competitive vs. beta-hydroxybutyrate
succinate
-
10 mM, 12% inhibition
Zn2+
inhibition and destabilization of the enzyme at 10 mM
acetoacetate
-
substrate inhibition, above 5 mM, noncompetitive vs. NADH
acetoacetate
-
inhibition above 1 mM, 2 mM, 89% inhibition
bromomalonate
-
-
Butyrate
-
5 mM, pH 8.5, 25°C, 22% inhibition
Butyrate
-
10 mM, 20% inhibition
chloromalonate
-
-
diazenedicarboxylic acid bis(dimethylamide)
-
0.20 mM, activity can be recovered with dithiothreitol, enzyme contains a vicinal dithiol that is oxidized by diamide
diazenedicarboxylic acid bis(dimethylamide)
-
NAD+ protects against inhibition
dimethylmalonate
-
15.3 mM, 50% inhibition, oxidation, 11.3% reduction
dimethylmalonate
-
7.6 mM, 50% inhibition, oxidation, 8.5 mM, reduction
HgCl2
-
enzyme extremely sensitive, NADH and Ca2+ protect
HgCl2
-
0.1 mM, 100% inhibition
Hydroxymalonate
-
4.8 mM, 50% inhibition, oxidation, 7.8 reduction
Hydroxymalonate
-
1.8 mM, 50% inhibition, oxidation, 6.0 mM, reduction
L-3-hydroxybutyrate
-
5 mM, pH 8.5, 25°C, 23% inhibition; 5 mM, pH 8.5, 25°C, 32% inhibition
L-3-hydroxybutyrate
-
is a competitive inhibitor
L-3-hydroxybutyrate
-
5 mM, 73% inhibition
malonate
-
-
malonate
-
9.5 mM, 50% inhibition, oxidation, 8.2 mM
malonate
-
3.7 mM, 50% inhibition, oxidation
malonate
-
10 mM, 66% inhibition, oxidation
mesoxalate
-
-
methylmalonate
-
-
methylmalonate
-
2.1 mM, 50% inhibition, oxidation
methylmalonate
-
1.4 mM, 50% inhibition, oxidation, 0.8 mM reduction
methylmalonate
-
brain 3-hydroxybutyrate dehydrogenase, 0.5 mM 69% inhibition, 0.75 mM 83%, 1 mM 87%, 1.5 mM 3-hydroxybutyrate, liver 3-hydroxybutyrate dehydrogenase, 0.1 mM 37% inhibition, 0.25 mM 41%, 0.5 mM 45%, 1 mM 3-hydroxybutyrate, competitive inhibition
N-ethylmaleimide
-
irreversible inhibition
N-ethylmaleimide
-
NAD+ protects against inhibition
NADH
-
competitive vs. NAD+
NADH
-
substrate inhibition, above 0.1 mM, competitive vs. acetoacetate
NADH
-
0.15 mM, 48% inhibition
p-chloromercuribenzoate
-
0.001 mM, extremely rapid inhibition, NAD+ and NADH protect against inhibition
p-chloromercuribenzoate
-
enzyme extremely sensitive, NADH and Ca2+ protect
p-chloromercuribenzoate
-
0.1 mM, 100% inhibition
Phenylglyoxal
-
extremely rapid inhibition
pyruvate
-
16.7 mM, pH 7.0, 22% inhibition
pyruvate
-
4 mM, 5% inhibition
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2-mercaptoethanol
-
10 mM, 41% increase
3-hydroxybutyrate
induces the enzyme when contained in the growth medium
EDTA
-
0.5 mM, 21% increase
KCN
-
0.1 mM, 37% increase
Lactate
induces the enzyme when contained in the growth medium
Phospholipids
-
absolutely dependent on
reduced glutathione
-
10 mM, 38% increase
succinate
induces the enzyme when contained in the growth medium
dithiothreitol
-
dithiothreitol
-
10 mM, 31% increase
phosphatidylcholine
-
-
phosphatidylcholine
-
required for formation of tight and functional complexes of enzyme with NAD+, coenzyme binding strengthens the interaction of the enzyme with phosphatidylcholine
phosphatidylcholine
-
state of phosphatidylcholine determines nature of activation, noncooperative for soluble phosphatidylcholine, cooperative for bilayer phosphatidylcholine
phosphatidylcholine
-
-
286513 , 286516 , 286517 , 286521 , 286525 , 286527 , 286528 , 286530 , 286535 , 286538 , 286540 , 286542 , 286543
phosphatidylcholine
-
state of phosphatidylcholine determines nature of activation, noncooperative for soluble phosphatidylcholine, cooperative for bilayer phosphatidylcholine
additional information
BDH1 is abundant in cells grown on D-fructose, D-glucose, maltose, oxaloacetate, 2-oxoglutarate, L-alanine, L-arginine, L-methionine, poly-3-hydroxybutyrate, and nutrient broth, and poor in cells grown on pyruvate, gluconate, fumarate, L-malate, propionate, and n-butyrate; BDH2 is abundant in cells grown on acetate, ethanol, D-arabinose, D-ribose, oxaloacetate, 2-oxoglutarate, malaete, L-histidine, L-alanine, L-arginine, L-methionine, and poly-3-hydroxybutyrate, and scant in cells grown on pyruvate, n-butyrate, and oleate; BDH3 is produced only in cells grown on 3-hydroxybutyrate or poly-3-hydroxybutyrate as a carbon source. Expression of bdh3 may be coordinately regulated with a gene encoding putative 3-hydroxybutyrate permease
-
additional information
BDH1 is abundant in cells grown on D-fructose, D-glucose, maltose, oxaloacetate, 2-oxoglutarate, L-alanine, L-arginine, L-methionine, poly-3-hydroxybutyrate, and nutrient broth, and poor in cells grown on pyruvate, gluconate, fumarate, L-malate, propionate, and n-butyrate; BDH2 is abundant in cells grown on acetate, ethanol, D-arabinose, D-ribose, oxaloacetate, 2-oxoglutarate, malaete, L-histidine, L-alanine, L-arginine, L-methionine, and poly-3-hydroxybutyrate, and scant in cells grown on pyruvate, n-butyrate, and oleate; BDH3 is produced only in cells grown on 3-hydroxybutyrate or poly-3-hydroxybutyrate as a carbon source. Expression of bdh3 may be coordinately regulated with a gene encoding putative 3-hydroxybutyrate permease
-
additional information
BDH1 is abundant in cells grown on D-fructose, D-glucose, maltose, oxaloacetate, 2-oxoglutarate, L-alanine, L-arginine, L-methionine, poly-3-hydroxybutyrate, and nutrient broth, and poor in cells grown on pyruvate, gluconate, fumarate, L-malate, propionate, and n-butyrate; BDH2 is abundant in cells grown on acetate, ethanol, D-arabinose, D-ribose, oxaloacetate, 2-oxoglutarate, malaete, L-histidine, L-alanine, L-arginine, L-methionine, and poly-3-hydroxybutyrate, and scant in cells grown on pyruvate, n-butyrate, and oleate; BDH3 is produced only in cells grown on 3-hydroxybutyrate or poly-3-hydroxybutyrate as a carbon source. Expression of bdh3 may be coordinately regulated with a gene encoding putative 3-hydroxybutyrate permease
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.34 - 131
(R)-3-hydroxybutanoate
0.45 - 2
(R)-3-hydroxybutyrate
0.28
3-acetylpyridine adenine dinucleotide
-
-
0.00547 - 32
acetoacetate
0.0391 - 260
beta-hydroxybutyrate
0.34 - 100
D-3-hydroxybutyrate
0.63 - 42.1
levulinic acid
additional information
additional information
-
0.34
(R)-3-hydroxybutanoate
30°C
0.49
(R)-3-hydroxybutanoate
30°C
0.59
(R)-3-hydroxybutanoate
-
submitochondrial vesicles
0.6
(R)-3-hydroxybutanoate
-
wild type enzyme
0.71
(R)-3-hydroxybutanoate
-
enzyme expressed in SF9 cells
1.2
(R)-3-hydroxybutanoate
-
-
1.5
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, wild-type enzyme
1.6
(R)-3-hydroxybutanoate
-
isoenzyme from heavy mitochondria
1.6
(R)-3-hydroxybutanoate
-
pH 8.0, 25°C
3.36
(R)-3-hydroxybutanoate
-
isoenzyme from light mitochondria
4
(R)-3-hydroxybutanoate
-
mutant enzyme H141A
9.1
(R)-3-hydroxybutanoate
-
30°C, pH 9.0
10
(R)-3-hydroxybutanoate
-
enzyme expressed in SF9 cells, C242S mutant, C242 important for substrate binding
10.5
(R)-3-hydroxybutanoate
-
25°C, pH 9.0
12.6
(R)-3-hydroxybutanoate
-
25°C, pH 7.5
35
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme H141A
51
(R)-3-hydroxybutanoate
-
mutant enzyme Q91A
70
(R)-3-hydroxybutanoate
-
mutant enzyme Q133A
78
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme K149R
96
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme Q193A
131
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme Q91A
0.45
(R)-3-hydroxybutyrate
oxidation reaction, pH 8.5, 55°C
0.633
(R)-3-hydroxybutyrate
-
euthermic state, liver
1.07
(R)-3-hydroxybutyrate
-
pH 8.1, 37°C
2
(R)-3-hydroxybutyrate
-
euthermic state, brain
0.00547
acetoacetate
-
-
0.146
acetoacetate
-
euthermic state, brain
0.149
acetoacetate
-
liver, soluble enzyme
0.15
acetoacetate
-
euthermic state, liver
0.17
acetoacetate
-
recombinant enzyme with N-terminal His-tag, at pH 6.5 and 30°C
0.24
acetoacetate
reduction reaction, pH 5.0, 55°C
0.29
acetoacetate
-
pH 7.0, 37°C
0.312
acetoacetate
-
heart, soluble enzyme
0.37
acetoacetate
-
wild-type
1.1
acetoacetate
-
mutant T190S
1.3
acetoacetate
-
mutant L215V
7.7
acetoacetate
-
mutant T190C
8.3
acetoacetate
-
mutant L215A
8.7
acetoacetate
-
cyanylated enzyme
10.47
acetoacetate
-
recombinant enzyme with C-terminal His-tag, at pH 6.5 and 30°C
32
acetoacetate
-
mutant T190A
0.0391
beta-hydroxybutyrate
-
-
0.32
beta-hydroxybutyrate
-
-
0.8
beta-hydroxybutyrate
-
-
0.866
beta-hydroxybutyrate
-
liver, soluble enzyme
1.05
beta-hydroxybutyrate
-
heart 3-hydroxybutyrate dehydrogenase
1.32
beta-hydroxybutyrate
-
liver 3-hydroxybutyrate dehydrogenase
1.586
beta-hydroxybutyrate
-
heart, soluble enzyme
2.2
beta-hydroxybutyrate
-
240 mM Na+, purified enzyme, reconstituted with total mitochondrial phospholipids
2.3
beta-hydroxybutyrate
-
-
2.3
beta-hydroxybutyrate
-
-
7.4
beta-hydroxybutyrate
-
-
21
beta-hydroxybutyrate
-
cyanylated enzyme
200
beta-hydroxybutyrate
-
240 mM Na+, purified enzyme, thiol group 1 modified with 1,1'-azobis(NN'-dimethylformamide), reconstituted with total mitochondrial phospholipids
260
beta-hydroxybutyrate
-
240 mM Na+, purified enzyme, thiol group 2 modified with 1,1'-azobis(NN'-dimethylformamide), reconstituted with total mitochondrial phospholipids
0.34
D-3-hydroxybutyrate
-
0.49
D-3-hydroxybutyrate
-
0.5
D-3-hydroxybutyrate
-
0.8
D-3-hydroxybutyrate
-
wild-type
0.88
D-3-hydroxybutyrate
-
H6-HBDH
1.2
D-3-hydroxybutyrate
-
mutant H6-W187Y
1.3
D-3-hydroxybutyrate
-
mutant H6-W187F
3.4
D-3-hydroxybutyrate
-
mutant L215V
3.7
D-3-hydroxybutyrate
-
mutant T190S
9.2
D-3-hydroxybutyrate
-
mutant L215A
25
D-3-hydroxybutyrate
-
mutant H6-H144A; mutant T190A
30
D-3-hydroxybutyrate
-
mutant H6-Q94A
31
D-3-hydroxybutyrate
-
mutant H6-K152R
36
D-3-hydroxybutyrate
-
mutant T190C
47
D-3-hydroxybutyrate
-
mutant H6-Q196A
51
D-3-hydroxybutyrate
-
mutant H6-Q196N
61
D-3-hydroxybutyrate
-
mutant H6-W257A
65
D-3-hydroxybutyrate
-
mutant H6-W257Y
83
D-3-hydroxybutyrate
-
mutant H6-Q196E; mutant H6-W257F
84
D-3-hydroxybutyrate
-
mutant H6-W187T
100
D-3-hydroxybutyrate
-
mutant H6-W187A
0.63
levulinic acid
-
recombinant mutant enzyme W187F with N-terminal His-tag, at pH 6.5 and 30°C
0.63
levulinic acid
-
mutant enzyme H144L/W187L, at pH 6.5 and 30°C; mutant enzyme W187F, at pH 6.5 and 30°C
0.64
levulinic acid
-
recombinant mutant enzyme H144L/W187F with N-terminal His-tag, at pH 6.5 and 30°C
0.64
levulinic acid
-
mutant enzyme H144L/W187F, at pH 6.5 and 30°C
0.78
levulinic acid
-
recombinant wild type enzyme with N-terminal His-tag, at pH 6.5 and 30°C
0.78
levulinic acid
-
wild type enzyme, at pH 6.5 and 30°C
0.91
levulinic acid
-
recombinant mutant enzyme H144L with N-terminal His-tag, at pH 6.5 and 30°C
0.91
levulinic acid
-
mutant enzyme H144L, at pH 6.5 and 30°C
1.72
levulinic acid
-
mutant enzyme H144F, at pH 6.5 and 30°C
2.81
levulinic acid
-
mutant enzyme H144I, at pH 6.5 and 30°C
3.84
levulinic acid
-
mutant enzyme H144V, at pH 6.5 and 30°C
4 - 5.4
levulinic acid
-
mutant enzyme W187I, at pH 6.5 and 30°C
8.25
levulinic acid
-
recombinant mutant enzyme H144L/W187F with C-terminal His-tag, at pH 6.5 and 30°C
9.87
levulinic acid
-
mutant enzyme H144A, at pH 6.5 and 30°C
13.03
levulinic acid
-
mutant enzyme H144L/W187A, at pH 6.5 and 30°C
13.49
levulinic acid
-
mutant enzyme W187L, at pH 6.5 and 30°C
16.98
levulinic acid
-
recombinant mutant enzyme H144L with C-terminal His-tag, at pH 6.5 and 30°C
25.57
levulinic acid
-
mutant enzyme H144L/W187V, at pH 6.5 and 30°C
25.76
levulinic acid
-
mutant enzyme H144L/W187I, at pH 6.5 and 30°C
36.83
levulinic acid
-
mutant enzyme W187A, at pH 6.5 and 30°C
42.1
levulinic acid
-
mutant enzyme W187V, at pH 6.5 and 30°C
0.000445
NAD+
-
-
0.0598
NAD+
-
25°C, pH 9.0
0.067
NAD+
-
heart, soluble enzyme
0.071
NAD+
-
liver, soluble enzyme
0.089
NAD+
oxidation reaction, pH 8.5, 55°C
0.12
NAD+
-
mutant H6-K152R; mutant H6-Q196A; mutant H6-Q196E
0.18
NAD+
-
23°C, pH 8.0, wild-type enzyme
0.19
NAD+
-
mutant H6-Q94A
0.2
NAD+
-
mutant H6-Q196N
0.21
NAD+
-
isoenzyme from heavy mitochondria
0.21
NAD+
-
mutant H6-W187Y
0.238
NAD+
-
euthermic state, liver
0.24
NAD+
-
liver 3-hydroxybutyrate dehydrogenase
0.24
NAD+
-
mutant H6-W187F; wild-type
0.27
NAD+
-
240 mM Na+, purified enzyme, reconstituted with total mitochondrial phospholipids
0.27
NAD+
-
23°C, pH 8.0, mutant enzyme Q193A
0.28
NAD+
-
23°C, pH 8.0, mutant enzyme H141A
0.35
NAD+
-
mutant H6-H144A
0.36
NAD+
-
heart 3-hydroxybutyrate dehydrogenase
0.38
NAD+
-
23°C, pH 8.0, mutant enzyme K149R
0.39
NAD+
-
isoenzyme from light mitochondria
0.49
NAD+
-
mutant H6-W257F
0.51
NAD+
-
23°C, pH 8.0, mutant enzyme Q91A
0.53
NAD+
-
enzyme expressed in SF9 cells
0.74
NAD+
-
mutant H6-W257Y
0.76
NAD+
-
mutant H6-W187A
0.8
NAD+
-
enzyme expressed in SF9 cells, C242S mutant
0.88
NAD+
-
mutant H6-W187T
0.902
NAD+
-
cyanylated enzyme
0.95
NAD+
-
submitochondrial vesicles
0.95
NAD+
-
mutant H6-W257A
1.187
NAD+
-
euthermic state, brain
0.00102
NADH
-
-
0.014
NADH
-
liver, soluble enzyme
0.029
NADH
-
heart, soluble enzyme
0.029
NADH
reduction reaction, pH 5.0, 55°C
0.058
NADH
-
euthermic state, brain
0.074
NADH
-
euthermic state, liver
0.164
NADH
-
cyanylated enzyme
additional information
additional information
-
dissociation constants for the cofactors and reaction kinetics at different physiological states in liver and brain
-
additional information
additional information
-
dissociation constants
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
13 - 1390
(R)-3-hydroxybutanoate
6.1 - 705
D-3-hydroxybutyrate
0.00016 - 0.2565
levulinic acid
13
(R)-3-hydroxybutanoate
-
mutant enzyme H141A
167
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme H141A
180
(R)-3-hydroxybutanoate
30°C
215
(R)-3-hydroxybutanoate
-
mutant enzyme Q133A
310
(R)-3-hydroxybutanoate
30°C
333
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme Q193A
404
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme K149R
411
(R)-3-hydroxybutanoate
-
mutant enzyme Q91A
432
(R)-3-hydroxybutanoate
-
wild type enzyme
1382
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, wild-type enzyme
1390
(R)-3-hydroxybutanoate
-
23°C, pH 8.0, mutant enzyme Q91A
4.5
acetoacetate
-
mutant T190A
4.9
acetoacetate
-
recombinant enzyme with C-terminal His-tag, at pH 6.5 and 30°C
5.1
acetoacetate
-
mutant T190C
30
acetoacetate
-
mutant L215A
87
acetoacetate
-
mutant L215V
97.16
acetoacetate
-
recombinant enzyme with N-terminal His-tag, at pH 6.5 and 30°C
120
acetoacetate
-
wild-type
125
acetoacetate
-
mutant T190S
6.1
D-3-hydroxybutyrate
-
mutant T190C
6.7
D-3-hydroxybutyrate
-
mutant H6-W257A
7.2
D-3-hydroxybutyrate
-
mutant H6-W187T
12
D-3-hydroxybutyrate
-
mutant H6-W257Y
21
D-3-hydroxybutyrate
-
mutant H6-H144A
22
D-3-hydroxybutyrate
-
mutant H6-Q196N; mutant T190A
29
D-3-hydroxybutyrate
-
mutant H6-W187A
70
D-3-hydroxybutyrate
-
mutant L215A
83
D-3-hydroxybutyrate
-
mutant H6-Q196E
88
D-3-hydroxybutyrate
-
mutant H6-W257F
99
D-3-hydroxybutyrate
-
mutant H6-Q196A
110
D-3-hydroxybutyrate
-
mutant H6-K152R
140
D-3-hydroxybutyrate
-
mutant H6-Q94A
180
D-3-hydroxybutyrate
-
180
D-3-hydroxybutyrate
-
mutant H6-W187Y
310
D-3-hydroxybutyrate
-
310
D-3-hydroxybutyrate
-
H6-HBDH; mutant H6-W187F
370
D-3-hydroxybutyrate
-
wild-type
435
D-3-hydroxybutyrate
-
mutant L215V
500
D-3-hydroxybutyrate
-
705
D-3-hydroxybutyrate
-
mutant T190S
0.00016
levulinic acid
-
mutant enzyme W187A, at pH 6.5 and 30°C
0.0003
levulinic acid
-
mutant enzyme W187I, at pH 6.5 and 30°C; mutant enzyme W187V, at pH 6.5 and 30°C
0.00084
levulinic acid
-
mutant enzyme H144A, at pH 6.5 and 30°C
0.00122
levulinic acid
-
mutant enzyme H144L/W187A, at pH 6.5 and 30°C
0.002
levulinic acid
-
mutant enzyme H144L/W187V, at pH 6.5 and 30°C
0.00289
levulinic acid
-
mutant enzyme H144L/W187I, at pH 6.5 and 30°C
0.00465
levulinic acid
-
mutant enzyme W187L, at pH 6.5 and 30°C
0.006
levulinic acid
-
recombinant wild type enzyme with N-terminal His-tag, at pH 6.5 and 30°C
0.00766
levulinic acid
-
mutant enzyme H144V, at pH 6.5 and 30°C
0.00768
levulinic acid
-
wild type enzyme, at pH 6.5 and 30°C
0.00921
levulinic acid
-
mutant enzyme H144F, at pH 6.5 and 30°C
0.01069
levulinic acid
-
mutant enzyme H144I, at pH 6.5 and 30°C
0.019
levulinic acid
-
recombinant mutant enzyme W187F with N-terminal His-tag, at pH 6.5 and 30°C
0.028
levulinic acid
-
recombinant mutant enzyme H144L with C-terminal His-tag, at pH 6.5 and 30°C
0.02969
levulinic acid
-
mutant enzyme W187F, at pH 6.5 and 30°C
0.06
levulinic acid
-
recombinant mutant enzyme H144L with N-terminal His-tag, at pH 6.5 and 30°C
0.06594
levulinic acid
-
mutant enzyme H144L, at pH 6.5 and 30°C
0.07107
levulinic acid
-
mutant enzyme H144L/W187L, at pH 6.5 and 30°C
0.079
levulinic acid
-
recombinant mutant enzyme H144L/W187F with C-terminal His-tag, at pH 6.5 and 30°C
0.164
levulinic acid
-
recombinant mutant enzyme H144L/W187F with N-terminal His-tag, at pH 6.5 and 30°C
0.2565
levulinic acid
-
mutant enzyme H144L/W187F, at pH 6.5 and 30°C
87
NAD+
30°C
58
NADH
30°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.47 - 560.1
acetoacetate
0.006 - 256.5
levulinic acid
0.47
acetoacetate
-
recombinant enzyme with C-terminal His-tag, at pH 6.5 and 30°C
560.1
acetoacetate
-
recombinant enzyme with N-terminal His-tag, at pH 6.5 and 30°C
0.006
levulinic acid
-
mutant enzyme W187A, at pH 6.5 and 30°C; wild type enzyme, at pH 6.5 and 30°C
0.008
levulinic acid
-
mutant enzyme H144A, at pH 6.5 and 30°C
0.013
levulinic acid
-
mutant enzyme W187V, at pH 6.5 and 30°C
0.014
levulinic acid
-
mutant enzyme W187I, at pH 6.5 and 30°C
0.016
levulinic acid
-
mutant enzyme H144F, at pH 6.5 and 30°C; mutant enzyme H144L/W187A, at pH 6.5 and 30°C
0.019
levulinic acid
-
mutant enzyme W187F, at pH 6.5 and 30°C
0.03
levulinic acid
-
mutant enzyme H144I, at pH 6.5 and 30°C; mutant enzyme H144V, at pH 6.5 and 30°C
0.045
levulinic acid
-
mutant enzyme H144L/W187L, at pH 6.5 and 30°C
0.051
levulinic acid
-
mutant enzyme H144L/W187V, at pH 6.5 and 30°C
0.06
levulinic acid
-
mutant enzyme H144L, at pH 6.5 and 30°C
0.063
levulinic acid
-
mutant enzyme W187L, at pH 6.5 and 30°C
0.074
levulinic acid
-
mutant enzyme H144L/W187I, at pH 6.5 and 30°C
0.164
levulinic acid
-
mutant enzyme H144L/W187F, at pH 6.5 and 30°C
1.62
levulinic acid
-
recombinant mutant enzyme H144L with C-terminal His-tag, at pH 6.5 and 30°C
7.68
levulinic acid
-
recombinant wild type enzyme with N-terminal His-tag, at pH 6.5 and 30°C
9.63
levulinic acid
-
recombinant mutant enzyme H144L/W187F with C-terminal His-tag, at pH 6.5 and 30°C
29.69
levulinic acid
-
recombinant mutant enzyme W187F with N-terminal His-tag, at pH 6.5 and 30°C
65.94
levulinic acid
-
recombinant mutant enzyme H144L with N-terminal His-tag, at pH 6.5 and 30°C
256.5
levulinic acid
-
recombinant mutant enzyme H144L/W187F with N-terminal His-tag, at pH 6.5 and 30°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.38 - 5.74
2,4-Dichlorophenoxyacetic acid
0.81
DL-2-hydroxybutyrate
-
-
3.38
2,4-Dichlorophenoxyacetic acid
-
pH 8.0, 25°C, versus NAD+
5.74
2,4-Dichlorophenoxyacetic acid
-
pH 8.0, 25°C, versus (R)-3-hydroxybutanoate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.02
-
cofactor 3-acetylpyridine adenine dinucleotide
0.038
-
brain 3-hydroxybutyrate dehydrogenase, mitochondrial extracts
0.07
-
heart 3-hydroxybutyrate dehydrogenase, mitochondrial extracts; kidney 3-hydroxybutyrate dehydrogenase, mitochondrial extracts
0.17
-
solubilized apo-3-hydroxybutyrate dehydrogenase, reconstituted with phosphatidylcholine/phosphatidylethanolamine/diphosphatidylglycerol, 5/4/1
0.22
-
apo-3-hydroxybutyrate dehydrogenase, reconstituted with phosphatidylcholine/phosphatidylethanolamine/diphosphatidylglycerol, 5/4/1
0.5
-
enzyme expressed in SF9 cells, S24T mutatant
0.52
-
submitochondrial vesicles, membrane bound enzyme
0.54
-
submitochondrial vesicles
0.6
-
enzyme expressed in SF9 cells, M92V mutatant
0.63
-
enzyme expressed in SF9 cells, membrane bound
0.8
-
enzyme expressed in SF9 cells, C242S mutatant
1.15
-
liver 3-hydroxybutyrate dehydrogenase, reconstituted with microsomal membranes
1.26
-
brain 3-hydroxybutyrate dehydrogenase, mitochondrial extracts
1.275
-
liver 3-hydroxybutyrate dehydrogenase, reconstituted with mitochondrial inner membranes
2.7
-
submitochondrial vesicles
41
-
purified enzyme, reconstituted with mitochondrial phospholipids
72
purified native enzyme
86
-
purified enzyme, reconstituted with mitochondrial phospholipids
91
-
liver 3-hydroxybutyrate dehydrogenase, reconstituted with mitochondrial phospholipids
145
-
heart 3-hydroxybutyrate dehydrogenase, reconstituted with mitochondrial phospholipids
300
purified recombinant enzyme
additional information
-
0.0018 mM/min/g wet weight
0.36
-
liver 3-hydroxybutyrate dehydrogenase, mitochondrial extracts
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4.5 - 5
reduction reaction
6 - 6.5
-
reduction of acetoacetate
6.4 - 7
-
reduction of acetoacetate
6.8
-
acetoacetate reduction
8.4
-
oxidation of beta-hydroxybutyrate
8.6
-
oxidation of (R)-3-hydroxybutanoate
7
-
approximately, reduction reaction
7
-
reduction of acetoacetate
8
-
-
8
-
approximately, oxidation reaction
8
-
isoenzyme from heavy and light mitochondria
8
-
oxidation of beta-hydroxybutyrate
8.5
oxidation reaction
8.5
-
oxidation of beta-hydroxybutyrate
9
oxidation
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5.5 - 7.5
-
acetoacetate reduction
5.9 - 8.6
-
acetoacetate reduction, 50% activity at pH 5.0, 66% at pH 8.6
6.5 - 8.5
optimal pH of BDH3 is 8.5 in the oxidation reaction and 6.5 in the reduction reaction
7.6 - 9
-
oxidation of beta-hydroxybutyrate
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
30
-
reduction reaction
35
-
isoenzyme from heavy mitochondria
35
-
for heavy mitochondria
37
-
-
40
-
isoenzyme from light mitochondria
40
-
for light mitochondria at euthermic state
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
20 - 60
-
30% of maximal activity at 20°C, 63% of maximal activity at 60°C
25 - 49
-
80% activity at 25°C and at 49°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
6
calculated from amino acid sequence; isoelectric focusing
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
gastric glandular mucosa
brenda
-
-
brenda
-
-
brenda
-
-
286513 , 286514 , 286516 , 286517 , 286521 , 286525 , 286528 , 286530 , 286535 , 286538 , 286540 , 286542
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
high activity
brenda
-
-
brenda
-
-
brenda
additional information
-
the enzyme is localized in poly(3-hydroxybutyrate) granules, co-localization with acetoacetyl-CoA thiolase and PHB synthase, overview
brenda
additional information
-
during the cold adaptation process, the prehibernating stage, the enzyme activity is decreased compared to euthermic state, in the hibernation state, the rate of acetoacetate reduction is increased in liver, while the oxidation of D-beta-hydroxybutyrate is increased in brain
brenda
additional information
-
the physiological states of the organism, i.e. euthermic, prehibernating, and hibernating, vary between in terms of ketone bodies, glucose and lipid levels, the enzyme might lead an important conformational change depending on the state, overview, enzyme expression is increased in hibernating state
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
located on the matrix face of the inner membrane
brenda
-
-
286514 , 286516 , 286517 , 286521 , 286522 , 286525 , 286527 , 286528 , 286530 , 286535 , 286542
brenda
-
-
brenda
-
located on the matrix face of the inner membrane
brenda
-
-
brenda
-
beta-hydroxybutyrate dehydrogenase from heavy and light mitochondria are isoforms
brenda
-
light and heavy mitochondria, enzyme expression and activity is increased in heavy mitochondria in hibernating state, overview
brenda
-
-
brenda
-
-
brenda
-
located on the matrix face of the inner membrane
brenda
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Rhizobium meliloti (strain 1021)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
23000
-
alpha4, 4 * 23000, SDS-PAGE
29000
-
4 * 29000, SDS-PAGE
31500
-
alpha4, 4 * 31500, SDS-PAGE
33117
-
alpha4, 4 * 33117, mature protein, calculated from deduced amino acid sequence
38000
-
alpha4, 4 * 38000, preprotein, calculated from deduced amino acid sequence
39000
-
alpha4, 4 * 39000, SDS-PAGE
67000
-
x * 67000, SDS-PAGE
68000
-
nondenaturing PAGE
106000
-
submitochondrial vesicles, radiation inactivation
119000
-
reconstituted enzyme, radiation inactivation, irradiation leads to loss of activity and fragmentation
27000
-
alpha4, 4 * 27000, sedimentation equilibrium
27000
-
alpha4, 4 * 27000, sedimentation equilibrium
27000
4 * 27000, SDS-PAGE
27000
-
x * 27000, SDS-PAGE
28000
-
alpha4, 4 * 28000, SDS-PAGE
28000
x * 28000, SDS-PAGE, BDH3
31000
-
alpha4, 4 * 31000, SDS-PAGE
31000
-
alpha4, 4 * 31000, SDS-PAGE
31000
4 * 31000, SDS-PAGE; 4 * 31000, SDS-PAGE
32000
-
alpha4, 4 * 32000, SDS-PAGE
32000
x * 32000, SDS-PAGE
110000
gel filtration
110000
gel filtration; gel filtration
120000
-
gel filtration
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
?
-
x * 67000, SDS-PAGE
?
x * 27600, calculated from amino acid sequence; x * 32000, SDS-PAGE
?
-
x * 27600, calculated from amino acid sequence; x * 32000, SDS-PAGE
-
?
x * 28000, SDS-PAGE, BDH3
?
-
x * 28000, SDS-PAGE, BDH3
-
homotetramer
-
x-ray crystallography
homotetramer
-
4 * 27200, calculated from amino acid sequence; 4 * 29000, SDS-PAGE
homotetramer
-
4 * 27200, calculated from amino acid sequence; 4 * 29000, SDS-PAGE
-
tetramer
4 * 27000, SDS-PAGE
tetramer
-
alpha4, 4 * 27000, sedimentation equilibrium; alpha4, 4 * 31000, SDS-PAGE
tetramer
-
alpha4, 4 * 31500, SDS-PAGE
tetramer
-
alpha4, 4 * 33117, mature protein, calculated from deduced amino acid sequence; alpha4, 4 * 38000, preprotein, calculated from deduced amino acid sequence
tetramer
-
alpha4, 4 * 32000, SDS-PAGE
tetramer
-
4 x 29000, SDS-PAGE
tetramer
-
x-ray crystallography
tetramer
4 * 31000, SDS-PAGE; 4 * 31000, SDS-PAGE
tetramer
-
4 * 31000, SDS-PAGE; 4 * 31000, SDS-PAGE
-
tetramer
-
alpha4, 4 * 27000, sedimentation equilibrium; alpha4, 4 * 31000, SDS-PAGE
tetramer
-
alpha4, 4 * 23000, SDS-PAGE
tetramer
-
alpha4, 4 * 39000, SDS-PAGE
tetramer
-
alpha4, 4 * 28000, SDS-PAGE
additional information
-
secondary and tertiary enzyme structure analysis, overview
additional information
-
three-dimensional structure modelling, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
crystallization of the enzyme in the apo form and in the holo form with acetate as a substrate analogue, method screening, mother liquor consists of 30% w/v PEG 4000, 0.2 M sodium acetate trihydrate and 100 mM Tris-HCl, pH 8.5, at 20°C, X-ray diffraction structure determination and analysis at 2.2 A resolution, molecular-replacement method
-
in complex with NAD+, malonate, or methylmalonate, hanging drop vapor diffusion method, using 30-34% (w/v) PEG 4000
-
in the presence of the substrate D-3-hydroxybutyrate and the cofactor NAD+ at the optimum pH for the catalytic reaction. At 277 and 293 K using the hanging-drop vapour-diffusion method, to 2.3 A resolution. Structure is isomorphous to that of the complex with the substrate analogue acetate
-
sitting drop vapor diffusion method at 20°C, structure determined at a resolution of 1.8 A in complex with NAD(H)
-
crystals of ternary complex of HBDH-NAD+-L-3-hydroxybutyrate and the binary complex of HBDH-NAD+. The former structure shows a closed-form conformation, which is considered an active form for catalysis, while the latter stays mostly in a open-form conformation. Crystals of mutants T190S and T190A
-
hanging-drop vapor-diffusion method, ligand-free enzyme and enzyme-NAD+ complex, 2.0 A resolution
-
hanging-drop vapour-diffusion method using PEG 3000 as a precipitating agent. The crystals belong to the orthorhombic group P2(1)2(1)2, with unit-cell parameters a = 64.3, b = 99.0, c = 110.2 A. The crystals are most likely to contain two tetrameric subunits in the asymmetric unit
Q5KST5
hanging drop vapour diffusion method with 17-20% polyethylene glycol 1500, 0.1 M Tris-HCl, pH 7.1, 0.2 mM CaCl2 and 10 mM acetoacetate; recombinant enzyme, hanging drop vapor diffusion method, 0.003 ml of HBDH, 10 mg/ml, is mixed with an equal volume of crystallization buffer containing 17-20% PEG 1500, 0.1 M Tris-HCl, pH 7.1, 0.2 mM CaCl2, and 10 mM acetoacetate, room temperature/22°C, three different crystal forms, X-ray diffraction structure determination and analysis at resolutions between 1.9 and 2.1 A
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0 - 37
-
stable at, 30% remaining activity after 40 min at 37°C, oxidation reaction
0 - 45
-
stable at 0°C and 25°C for 90 min, 18% activity after 90 min at 45°C, activity restored after 60 min at 37°C, loss of activity at 60°C
45
-
25% remaining activity after 20 min, oxidation reaction
60
-
28% remaining activity
37
-
loss of 70% activity after 15 min, 0.24 mg protein/ml, Ca2+ and Mn2+ stabilize enzyme
37
-
75% activity after 30 min in buffer containing 1 mM Ca2+, 46% with 1 mM MnCl2
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
the enzyme with an N-terminal His-tag has approximately 1200fold higher catalytic efficiency than its C-terminal counterpart and exhibits higher catalytic efficiency for levulinic acid than the C-terminal
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-20°C, 1 mg enzyme/ml, 0.2 mM potassium phosphate pH 8.0, 10% glycerol, 10 mM 2-mercaptoethanol, 6 months, 0% inactivation, 0°C, 0.1 mg enzyme/ml, 1 day, 50% inactivation
-
-20°C, 20 mM phosphate buffer, pH 7.0, 20% glycerol
-20°C, crude extract, partially purified enzyme, several weeks, 0% inactivation
-
-20°C, several months, 0%, 4°C, lyophilized, 2 month, 0% inactivation, 4°C, 0.1 M sodium phosphate buffer pH 7-8, 5 days, 50% inactivation, stability increases in the presence of 1-10 mM EDTA
-
4°C, Tris-HCl buffer, 50-100 mM Mg2+, Mn2+, Ba2+, or Ca2+, enzyme loses all activity in the presence of phosphate buffer or EDTA within 2 min
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
about 1000fold, to homogeneity from liver mitochondrial membranes by solubilization with Triton X-100, DEAE-ion-exchange chromatography and phenyl-resin chromatography
-
affinity chromatography on two triazine dyes
-
ammonium sulfate precipitation, DEAE-cellulose
-
ammonium sulfate precipitation, DEAE-Sephadex, Sephadex G-200
-
ammonium sulfate, acid precipitation, DEAE-Sepharose, glass beads
-
ammonium sulfate, DEAE-Sepharose, 60°C, 10 min, hydroxylapatite, octyl-Sepharose, Sephadex G-200, DEAE-Sepharose
-
BDH3 partially purified from bdh2 mutant by three steps of column chromatography. Gene product of bdh3 expressed in Escherichia coli purified with 100% yield by two steps of column chromatography
charge-controlled hydrophobic chromatography and Sephadex G-100 gel filtration
-
DEAE-cellulose, Matrex gel blue A, Sephadex G-200, chromatofocusing
-
native by 3 chromatographic steps, recombinant from Escherichia coli in 2chromatographic steps
native enzyme by ammonium sulfate fractionation and affinity chromatography
-
Ni-NTA column chromatography
-
Ni-NTA column chromatography, and TSK gel G3000SW gel filtration
-
phospholipase A2 treatment, controlled-pore glass beads
protamine sulfate precipitation, Sephacryl S-400, S200, DEAE-Sepharose
-
recombinant C-terminally His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21 (DE3) by nickel affinity chromatography
-
recombinant enzyme from Escherichia coli strain DH1 by anion exchange chromatography, hydrophobic interaction chromatography using a gradient of 1-20% ammonium sulfate, and ultrafiltration
-
wild-type and mutants purified by metal chelating affinity chromatography followed by ion-exchange chromatography
-
-
-
phospholipase A2 treatment, controlled-pore glass beads
-
phospholipase A2 treatment, controlled-pore glass beads
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
BDH3 expressed in Escherichia coli BLR (DE3)/pLysS harboring pETT13
DNA and amino acid sequence determination and analysis
-
DNA and amino acid sequence determination and analysis, overexpression in Escherichia coli strain BL21(DE3)
efficiently expressed in Escherichia coli cells harboring pHBDH11
-
enzyme expression in Escherichia coli strain DH1
-
enzyme expression in Escherichia coli strain XL-1 Blue; expressed in Escherichia coli XL1-Blue cells
-
expressed in Escherichia coli BL21(DE3) cells
expression in Escherichia coli
-
expression in Escherichia coli; expression in Escherichia coli
expression of C-terminally His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21 (DE3)
-
functional co-expression with acetoacetyl-CoA thiolase and PHB synthase in Escherichia coli, recombinant production of poly(3-hydroxybutanoate) granules, overview
-
His-tagged 3-hydroxybutyrate dehydrogenase, expressed in Escherichia coli
-
mature form, expressed in Spodoptera frugiperda, SF9 cells
-
wild-type and mutants expressed in Escherichia coli XL1Blue harbouring pHBDH11. Wild-type HBDH and mutants containing an N-terminal His-tag expressed in Escherichia coli XL1Blue using pQE30 as a vector
-
expressed in Escherichia coli BL21(DE3) cells
-
expressed in Escherichia coli BL21(DE3) cells
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
H144A
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
H144F
-
the mutant shows increased catalytic efficiency with levulinic acid compared to the wild type enzyme
H144I
-
the mutant shows increased catalytic efficiency with levulinic acid compared to the wild type enzyme
H144L/W187A
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
H144L/W187I
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
H144L/W187L
-
the mutant shows strongly increased catalytic efficiency with levulinic acid compared to the wild type enzyme
H144L/W187V
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
H144V
-
the mutant shows wild type catalytic efficiency with levulinic acid
W187A
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
W187I
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
W187L
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
W187V
-
the mutant shows reduced catalytic efficiency with levulinic acid compared to the wild type enzyme
C242S
-
PCR derived cDNA clone
M92V
-
PCR derived cDNA clone
S24T
-
PCR derived cDNA clone
H144A
-
catalytic efficiency (kcat/Km) is 0.2% of the activity of wild-type HBDH
K152E
-
very low activity
K152Q
-
very low activity
K152R
-
retains a significant level of activity
L215A
-
both Km and kcat values are largely affected and the catalytic efficiency (kcat/Km) is less than 3% that of the wild-type enzyme
L215V
-
Km values increase 3.5- and 4.3fold and the kcat values are 73-118% those of the wild-type toward D-3-hydroxybutyrate and acetoacetate, respectively. Mutation does not significantly change Km and kcat toward NAD+ and NADH
Q196A
-
kcat/Km value is 0.6% that of the wild-type
Q196E
-
substantially reduced activity
Q196N
-
substantially reduced activity
Q94A
-
catalytic efficiency (kcat/Km) is 1.4% of the activity of wild-type HBDH
T190A
-
activity decreases to 0.1% that of the wild-type enzyme
T190C
-
decreased activity
T190S
-
retains 37% of the activity
W187A
-
very low activity
W187F
-
shows significant activity levels, 65% that of the wild-type enzyme
W187T
-
shows faint activity
W187Y
-
shows significant activity levels, 41% that of the wild-type enzyme
W257F
-
shows low activity levels, 2% that of the wild-type enzyme
W257Y
-
shows low activity levels, 1% that of the wild-type enzyme
K149A
-
inactive mutant enzyme
K149R
-
kcat/KM for (R)-3-hydroxybutanoate is 184.2fold lower than wild-type value, kcat/Km for NAD+ is 7.2fold lower than wild-type enzyme
Q133A
-
decreased activity
Q193A
-
kcat/KM for (R)-3-hydroxybutanoate is 307fold lower than wild-type value, kcat/Km for NAD+ is 6.2fold lower than wild-type enzyme
H144L
-
the mutant shows activity with levulinic acid
H144L
-
the mutant shows increased catalytic efficiency with levulinic acid compared to the wild type enzyme
H144L/W187F
-
site-directed mutagenesis, the mutant shows activity with levulinnic acid, in contrast to the wild-type enzyme, and is engineered for production of 4-hydroxyvaleric acid, molecular docking simulation, overview
H144L/W187F
-
the mutant shows activity with levulinic acid
H144L/W187F
-
the mutant shows strongly increased catalytic efficiency with levulinic acid compared to the wild type enzyme
W187F
-
the mutant shows activity with levulinic acid
W187F
-
the mutant shows increased catalytic efficiency with levulinic acid compared to the wild type enzyme
H141A
-
kcat/KM for (R)-3-hydroxybutanoate is 184.2fold lower than wild-type value, kcat/Km for NAD+ is 12.9fold lower than wild-type enzyme
H141A
-
strongly decreased activity
Q91A
-
kcat/KM for (R)-3-hydroxybutanoate is 83.7fold lower than wild-type value, kcat/Km for NAD+ is 2.8fold lower than wild-type enzyme
Q91A
-
decreased activity
additional information
the bdh1 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH1 causes a decline in the capacity to neutralize the stress; the bdh2 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH2 causes a decline in the capacity to neutralize the stress
additional information
the bdh1 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH1 causes a decline in the capacity to neutralize the stress; the bdh2 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH2 causes a decline in the capacity to neutralize the stress
additional information
the bdh1 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH1 causes a decline in the capacity to neutralize the stress; the bdh2 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH2 causes a decline in the capacity to neutralize the stress
additional information
-
the bdh1 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH1 causes a decline in the capacity to neutralize the stress; the bdh2 mutant lags behind the wild-type in growth rates when the cells are cultured with 3-hydroxybutyrate, citrate, succinate, or nutrient broth. A test of sensitivity to diamide as an oxidative stress reveals that the lack of BDH2 causes a decline in the capacity to neutralize the stress
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
diagnostics
-
the enzyme is a useful marker in the assay of diabetes mellitus and/or ketoacidosis
synthesis
-
the engineered enzyme mutant H144L/W187F is used for production of 4-hydroxyvaleric acid, a monomer of bio-polyester and a precursor of bio-fuels, from levulinic acid
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Brain Neoplasms
The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Carcinoma
Monitoring by alpha-hydroxybutyrate dehydrogenase of human ovarian carcinoma grown in nude mice.
Carcinoma, Hepatocellular
Immunochemical analysis of the membrane proteins of rat liver and Zajdela hepatoma mitochondria.
Carcinoma, Hepatocellular
Regulation of D-beta-hydroxybutyrate dehydrogenase in rat hepatoma cell lines.
Carcinoma, Hepatocellular
[Activity of the beta-hydroxybutyric dehydrogenase of mitochondria of ascitic hepatoma and of the normal rat liver.]
Cardiomegaly
Cardiac hypertrophy in spontaneously hypertensive rats. Ultrastructural cytochemistry of beta-hydroxybutyrate dehydrogenase [proceedings]
Cardiomegaly
Proceedings: Cardiac hypertrophy in spontaneously hypertensive rats. I. Chronological changes in the mitochondrial beta-hydroxybutyrate dehydrogenase activity in the myocardium.
Diabetes Mellitus
Metabolic control of the expression of mitochondrial D-beta-hydroxybutyrate dehydrogenase, a ketone body converting enzyme.
Diabetes Mellitus
The effect of spontaneous diabetes mellitus on fatty acid oxidation, beta-hydroxybutyrate dehydrogenase activity and respiratory coupling of hepatic mitochondria in the guinea-pig (Cavia porcellus).
Diabetes Mellitus
The structures of Alcaligenes faecalis D-3-hydroxybutyrate dehydrogenase before and after NAD+ and acetate binding suggest a dynamical reaction mechanism as a member of the SDR family.
Diabetes Mellitus, Experimental
Variations of specific mRNA and polypeptide contents of rat liver D-beta-hydroxybutyrate dehydrogenase during an experimental diabetes mellitus.
Glioma
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.
Heart Failure
[Histochemical study of the enzyme activity of the myocardium of sudden death victims with postinfarct cardiosclerosis]
Hutchinson's Melanotic Freckle
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Hyperthyroidism
Accelerated postnatal development of D(-)- -hydroxybutyrate dehydrogenase (EC 1.1.1.30) activity in the brain in hyperthyroidism.
Hyperthyroidism
Concerning the decreased D-3-hydroxybutyrate dehydrogenase activity in the liver and heart of hyperthyroid rats.
Hyperthyroidism
Differential action of thyroid hormones on the activity of certain enzymes in rat kidney and brain.
Hyperthyroidism
Ketone-body metabolism in hyperthyroid rats: reduced activity of D-3-hydroxybutyrate dehydrogenase in both liver and heart and of succinyl-coenzyme A: 3-oxoacid coenzyme A-transferase in heart.
Hypothyroidism
Mitochondrial oxidative enzyme activity in individual fibre types in hypo- and hyperthyroid rat skeletal muscles.
Hypothyroidism
[Enzymatic and immunologic study of the role of the thyroid hormone in the formation of the internal mitochondrial membrane during postnatal development of the rat]
Infection
Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages.
Ketosis
Effect of prenatally-induced and postnatally-maintained ketosis on beta-hydroxybutyrate dehydrogenase and hexokinase levels in the developing rat brain.
Ketosis
The structures of Alcaligenes faecalis D-3-hydroxybutyrate dehydrogenase before and after NAD+ and acetate binding suggest a dynamical reaction mechanism as a member of the SDR family.
Melanoma
Histochemical findings in different types of malignant melanoma: biological and clinical significance.
Neoplasms
Beta-hydroxybutyrate dehydrogenase activity in liver and liver tumors.
Neoplasms
Fatty acid oxidation, substrate shuttles, and activity of the citric acid cycle in hepatocellular carcinomas of varying differentiation.
Neoplasms
Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.
Neoplasms
Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo.
Neoplasms
Monitoring by alpha-hydroxybutyrate dehydrogenase of human ovarian carcinoma grown in nude mice.
Neoplasms
The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Obesity
Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice.
Reperfusion Injury
[Transmural differences between damaged cardiomyocytes due to post-ischemic reperfusion and calcium paradox]
Starvation
Activities of some key enzymes of carbohydrate, ketone body, adenosine and glutamine metabolism in liver, and brown and white adipose tissues of the rat.
Starvation
Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Loeb-Hennard, C.; McIntyre, J.O.
(R)-3-Hydroxybutyrate dehydrogenase: selective phosphatidylcholine binding by the C-terminal domain
Biochemistry
39
11929-11938
2000
Homo sapiens
-
brenda
Green, D.; Marks, a.R.; Fleischer, S.; McIntyre, J.O.
Wild type and mutant human heart (R)-3-hydroxybutyrate dehydrogenase expressed in insect cells
Biochemistry
35
8158-8165
1996
Bos taurus, Homo sapiens
brenda
Klein, K.; Rudy, B.; McIntyre, J.O.; Fleischer, S.; Trommer, W.E.
Specific interaction of(R)-3-hydroxybutyrate dehydrogenase with membrane phosphatidylcholine as studied by ESR spectroscopy in oriented phospholipid multilayers: coenzyme binding enhances the interaction with phosphatidylcholine
Biochemistry
35
3044-3049
1996
Bos taurus
brenda
Szewczyk, E.; Rozolska, M.
Occurence, purification and properties of the staphylococcal beta-hydroxybutyrate dehydrogenase
Acta Microbiol. Pol.
43
33-45
1994
Staphylococcus xylosus
brenda
Adam, Pascal; Duncan, T.M.; McIntyre, J.O.; Carter, C.E.; Fu, C.; Melin, M.; Latruffe, N.; Fleischer, S.
Monoclonal antibodies for structure-function studies of (R)-3-hydroxybutyrate dehydrogenase, a lipid-dependent membrane-bound enzyme
Biochem. J.
292
863-872
1993
Bos taurus, Rattus norvegicus
brenda
Dalton, L.A.; McIntyre, J.O.; Fleischer, S.
Effect of selective thiol-group derivatization on enzyme kinetics of (R)3-hydroxybutyrate dehydrogenase
Biochem. J.
296
563-569
1993
Bos taurus
brenda
Dutra, J.C.; Dutra-Filho, C.S.; Cardozo, S.E.C.; Wannmacher, C.M.D.; Sarkis, J.J.F.; Wajner, M.
Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats
J. Inherit. Metab. Dis.
16
147-153
1993
Rattus norvegicus
brenda
Marks, A.R.; McIntyre, J.O.; Duncan, T.M.; Erdjument-Bromage, H.; Tempst, P.; Fleischer, S.
Molecular cloning and characterization of (R)3-hydroxybutyrate dehydrogenase from human heart
J. Biol. Chem.
267
15459-15463
1992
Homo sapiens
brenda
Bailly, A.; Lone, Y.C.; Latruffe, N.
Post-transcriptional analysis of rat mitochondrial D-3-hydroxybutyrate dehydrogenase control through development and physiological stages
Biol. Cell.
73
121-129
1991
Rattus norvegicus
brenda
McIntyre, J.O.; Latruffe, N.; Brenner, S.C.; Fleischer, S.
Comparison of 3-hydroxybutyrate dehydrogenase from bovine heart and rat liver mitochondria
Arch. Biochem. Biophys.
262
85-98
1988
Bos taurus, Rattus norvegicus
brenda
Cortese, J.D.; Fleischer, S.
Noncooperative vs. cooperative reactivation of D-beta-hydroxybutyrate dehydrogenase: multiple equilibria for lecithin binding are determined by the physical state (soluble vs. bilayer) and composition of the phospholipids
Biochemistry
26
5283-5293
1987
Bos taurus, Rattus norvegicus
brenda
Worral, E.B.; Gassain, S.; Cox, D.J.; Sugden, M.C.; Palmer, T.N.
3-Hydroxyisobutyrate dehydrogenase, an impurity in commercial 3-hydroxybutyrate dehydrogenase
Biochem. J.
241
297-300
1987
Rhodobacter sphaeroides
brenda
Kovar, J.; Matyskova, I.; Matyska, L.
Kinetics of D-3-hydroxybutyrate dehydrogenase from Paracoccus denitrificans
Biochim. Biophys. Acta
871
302-309
1986
Paracoccus denitrificans
-
brenda
Dubois, H.; Fritsche, T.M.; Trommer, W.E.; McIntyre, J.O.; Fleischer, S.
Cyanylation of 3-hydroxybutyrate dehydrogenase
Biol. Chem. Hoppe-Seyler
367
343-353
1986
Bos taurus
brenda
Matyskova I.; Kovar, J.; Racek, P.
Purification and properties of D-3-hydroxybutyrate dehydrogenase from Paracoccus denitrificans
Biochim. Biophys. Acta
839
300-307
1985
Paracoccus denitrificans
-
brenda
Burnett, B.K.; Khorana, H.G.
A rapid and efficient procedure for the purification of mitochondrial beta-hydroxybutyrate dehydrogenase
Biochim. Biophys. Acta
815
51-56
1985
Bos taurus
brenda
Phelps, D.C.; Hatefi, Y.
Inhibition of D(-)-beta-hydroxybutyrate dehydrogenase by butanedione, phenylglyoxal, and diethyl pyrocarbonate
Biochemistry
20
459-463
1981
Bos taurus
brenda
MacGill, A.K.; Anderson, N.G.; Trotman, C.N.A.; Carrington, J.M.; Hanson, P.J.
D-3-Hydroxybutyrate dehydrogenase and metabolism of ketone bodies by rat stomach
Biochem. Soc. Trans.
607
788
1984
Rattus norvegicus
-
brenda
McIntyre, J.O.; Churchill, P.; Maurer, A.; Berenski, C.J.; Jung, C.Y.; Fleischer, S.
Target size of D-beta-hydroxybutyrate dehydrogenase
J. Biol. Chem.
258
953-959
1983
Bos taurus
brenda
Scawen, M.D.; Darbyshire, J.; Harvey, M.J.; Atkinson, T.